NVCR

SEC source: 0001997032-26-000006 · primarydocument.xml · nonDerivative · entry 1

Puri Michal Nath · CIK 0001997032 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,227

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026.

SEC source: 0001822879-26-000006 · primarydocument.xml · nonDerivative · entry 1

Leonard Frank X · CIK 0001822879 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 461,425

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026.

SEC source: 0001917165-26-000006 · primarydocument.xml · nonDerivative · entry 1

Ben Arye Barak · CIK 0001917165 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,752

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026.

SEC source: 0001654435-26-000003 · primarydocument.xml · nonDerivative · entry 1

Danziger Asaf · CIK 0001654435 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 416,742

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the 2025 NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2026 through June 30, 2026. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 1, 2026.

SEC source: 0001822879-26-000004 · primarydocument.xml · nonDerivative · entry 1

Leonard Frank X · CIK 0001822879 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 459,520

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.665 USD to $18.37 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001970438-26-000002 · primarydocument.xml · derivative · entry 2

Stafford Kristin · CIK 0001970438 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,999

Underlying: Ordinary Shares · 16,999 shares

Expires 2036-06-03

F2 · derivative.exercise_date: Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001970438-26-000002 · primarydocument.xml · nonDerivative · entry 1

Stafford Kristin · CIK 0001970438 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,934

F1 · security: Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001236183-26-000002 · primarydocument.xml · derivative · entry 2

LEUNG GABRIEL · CIK 0001236183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,999

Underlying: Ordinary Shares · 16,999 shares

Expires 2036-06-03

F2 · derivative.exercise_date: Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001236183-26-000002 · primarydocument.xml · nonDerivative · entry 1

LEUNG GABRIEL · CIK 0001236183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,109

F1 · security: Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001967326-26-000002 · primarydocument.xml · derivative · entry 2

Ocean Allyson J · CIK 0001967326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,999

Underlying: Ordinary Shares · 16,999 shares

Expires 2036-06-03

F2 · derivative.exercise_date: Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001967326-26-000002 · primarydocument.xml · nonDerivative · entry 1

Ocean Allyson J · CIK 0001967326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,934

F1 · security: Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001451533-26-000002 · primarydocument.xml · derivative · entry 2

Scannell Timothy J · CIK 0001451533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,999

Underlying: Ordinary Shares · 16,999 shares

Expires 2036-06-03

F2 · derivative.exercise_date: Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001451533-26-000002 · primarydocument.xml · nonDerivative · entry 1

Scannell Timothy J · CIK 0001451533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,898

F1 · security: Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001216628-26-000002 · primarydocument.xml · derivative · entry 2

HILLEMAN JERYL L · CIK 0001216628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,999

Underlying: Ordinary Shares · 16,999 shares

Expires 2036-06-03

F2 · derivative.exercise_date: Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001216628-26-000002 · primarydocument.xml · nonDerivative · entry 1

HILLEMAN JERYL L · CIK 0001216628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,471

F1 · security: Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001310880-26-000006 · primarydocument.xml · derivative · entry 2

Hung David · CIK 0001310880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,999

Underlying: Ordinary Shares · 16,999 shares

Expires 2036-06-03

F2 · derivative.exercise_date: Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001310880-26-000006 · primarydocument.xml · nonDerivative · entry 1

Hung David · CIK 0001310880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,075

F1 · security: Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001696864-26-000001 · primarydocument.xml · derivative · entry 2

Madden Martin J. · CIK 0001696864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,999

Underlying: Ordinary Shares · 16,999 shares

Expires 2036-06-03

F2 · derivative.exercise_date: Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001696864-26-000001 · primarydocument.xml · nonDerivative · entry 1

Madden Martin J. · CIK 0001696864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,284

F1 · security: Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001369091-26-000005 · primarydocument.xml · derivative · entry 2

VERNON W ANTHONY · CIK 0001369091 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,999

Underlying: Ordinary Shares · 16,999 shares

Expires 2036-06-03

F2 · derivative.exercise_date: Options to buy ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001369091-26-000005 · primarydocument.xml · nonDerivative · entry 1

VERNON W ANTHONY · CIK 0001369091 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,267

F1 · security: Represents restricted stock units that are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2027 annual general meeting of shareholders.

SEC source: 0001970438-26-000001 · primarydocument.xml · nonDerivative · entry 1

Stafford Kristin · CIK 0001970438 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,324

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001236183-26-000001 · primarydocument.xml · nonDerivative · entry 1

LEUNG GABRIEL · CIK 0001236183 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,499

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001967326-26-000001 · primarydocument.xml · nonDerivative · entry 1

Ocean Allyson J · CIK 0001967326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,324

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001451533-26-000001 · primarydocument.xml · nonDerivative · entry 1

Scannell Timothy J · CIK 0001451533 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,288

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001216628-26-000001 · primarydocument.xml · nonDerivative · entry 1

HILLEMAN JERYL L · CIK 0001216628 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,861

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001369091-26-000004 · primarydocument.xml · nonDerivative · entry 1

VERNON W ANTHONY · CIK 0001369091 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,657

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001310880-26-000005 · primarydocument.xml · nonDerivative · entry 1

Hung David · CIK 0001310880 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,465

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.65 USD to $15.88 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001369091-26-000002 · primarydocument.xml · derivative · entry 2

VERNON W ANTHONY · CIK 0001369091 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 21,500 shares

Expires 2026-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001369091-26-000002 · primarydocument.xml · nonDerivative · entry 1

VERNON W ANTHONY · CIK 0001369091 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,602

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002039078-26-000005 · primarydocument.xml · nonDerivative · entry 3

Paravasthu Mukund · CIK 0002039078 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,832

F4 · price: This transaction was executed in multiple trades at prices ranging from $13.74 USD to $14.07 USD; the price reported above reflects the weighted average sale price.

SEC source: 0002039078-26-000005 · primarydocument.xml · nonDerivative · entry 2

Paravasthu Mukund · CIK 0002039078 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,078

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001811030-26-000003 · primarydocument.xml · nonDerivative · entry 2

Weinberg Uri · CIK 0001811030 · Chf Medical and Innovation Ofr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,190

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.

SEC source: 0002007766-26-000003 · primarydocument.xml · nonDerivative · entry 1

Leupin Nicolas · CIK 0002007766 · Former Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,979

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001822014-26-000003 · primarydocument.xml · nonDerivative · entry 1

Cordova Ashley · CIK 0001822014 · Former Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 422,570

F1 · shares: Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).

SEC source: 0002048634-26-000001 · primarydocument.xml · nonDerivative · entry 2

Brackmann Christoph · CIK 0002048634 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,842

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001822879-26-000003 · primarydocument.xml · nonDerivative · entry 2

Leonard Frank X · CIK 0001822879 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 493,793

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.

SEC source: 0001997032-26-000004 · primarydocument.xml · nonDerivative · entry 2

Puri Michal Nath · CIK 0001997032 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,322

F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $13.21 USD to $13.445 USD; the price reported above reflects the weighted average sale price.

SEC source: 0002039078-26-000005 · primarydocument.xml · derivative · entry 5

Paravasthu Mukund · CIK 0002039078 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,006

Underlying: Ordinary Shares · 58,488 shares

Expires 2036-03-03

F5 · derivative.exercise_date: Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.

SEC source: 0002039078-26-000005 · primarydocument.xml · derivative · entry 4

Paravasthu Mukund · CIK 0002039078 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,518

Underlying: Ordinary Shares · 7,518 shares

Expires 2036-03-03

F5 · derivative.exercise_date: Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.

SEC source: 0002039078-26-000005 · primarydocument.xml · nonDerivative · entry 1

Paravasthu Mukund · CIK 0002039078 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,455

F1 · security: Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.

SEC source: 0001811030-26-000003 · primarydocument.xml · derivative · entry 3

Weinberg Uri · CIK 0001811030 · Chf Medical and Innovation Ofr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,340

Underlying: Ordinary Shares · 73,340 shares

Expires 2036-03-03

F4 · derivative.exercise_date: Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.

SEC source: 0001811030-26-000003 · primarydocument.xml · nonDerivative · entry 1

Weinberg Uri · CIK 0001811030 · Chf Medical and Innovation Ofr

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,602

F1 · security: Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.

SEC source: 0001917165-26-000004 · primarydocument.xml · derivative · entry 2

Ben Arye Barak · CIK 0001917165 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,340

Underlying: Ordinary Shares · 73,340 shares

Expires 2036-03-03

F2 · derivative.exercise_date: Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.

SEC source: 0001917165-26-000004 · primarydocument.xml · nonDerivative · entry 1

Ben Arye Barak · CIK 0001917165 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,453

F1 · security: Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.

SEC source: 0002048634-26-000001 · primarydocument.xml · derivative · entry 3

Brackmann Christoph · CIK 0002048634 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,674

Underlying: Ordinary Shares · 80,674 shares

Expires 2036-03-03

F4 · derivative.exercise_date: Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.

SEC source: 0002048634-26-000001 · primarydocument.xml · nonDerivative · entry 1

Brackmann Christoph · CIK 0002048634 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 189,254

F1 · security: Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.

SEC source: 0001822879-26-000003 · primarydocument.xml · derivative · entry 3

Leonard Frank X · CIK 0001822879 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,388

Underlying: Ordinary Shares · 216,388 shares

Expires 2036-03-03

F4 · derivative.exercise_date: Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.

SEC source: 0001822879-26-000003 · primarydocument.xml · nonDerivative · entry 1

Leonard Frank X · CIK 0001822879 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 499,400

F1 · security: Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.

SEC source: 0001997032-26-000004 · primarydocument.xml · derivative · entry 3

Puri Michal Nath · CIK 0001997032 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,672

Underlying: Ordinary Shares · 58,672 shares

Expires 2036-03-03

F4 · derivative.exercise_date: Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.